Hepatocellular carcinoma (primer)

JM Llovet, RK Kelley, A Villanueva… - Nature Reviews …, 2021 - search.proquest.com
Liver cancer remains a global health challenge, with an estimated incidence of> 1 million
cases by 2025. Hepatocellular carcinoma (HCC) is the most common form of liver cancer …

A global view of hepatocellular carcinoma: trends, risk, prevention and management

JD Yang, P Hainaut, GJ Gores, A Amadou… - Nature reviews …, 2019 - nature.com
Hepatocellular carcinoma (HCC) is the fourth most common cause of cancer-related death
worldwide. Risk factors for HCC include chronic hepatitis B and hepatitis C, alcohol …

EASL recommendations on treatment of hepatitis C: final update of the series☆

JM Pawlotsky, F Negro, A Aghemo, M Berenguer… - Journal of …, 2020 - Elsevier
Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with
approximately 71 million chronically infected individuals worldwide. Clinical care for patients …

Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases

JA Marrero, LM Kulik, CB Sirlin, AX Zhu, RS Finn… - Hepatology, 2018 - journals.lww.com
This guidance provides a data-supported approach to the diagnosis, staging, and treatment
of patients diagnosed with hepatocellular carcinoma (HCC). A guidance document is …

Epidemiology and management of hepatocellular carcinoma

L Kulik, HB El-Serag - Gastroenterology, 2019 - Elsevier
The major risk factors for hepatocellular carcinoma (HCC) in contemporary clinical practice
are becoming increasingly related to sustained virological response after hepatitis C …

EASL clinical practice guidelines: management of hepatocellular carcinoma

PR Galle, A Forner, JM Llovet, V Mazzaferro… - Journal of …, 2018 - Elsevier
Liver cancer is the fifth most common cancer and the second most frequent cause of cancer-
related death globally. Hepatocellular carcinoma represents about 90% of primary liver …

[HTML][HTML] Predictors of early and late hepatocellular carcinoma recurrence

R Nevola, R Ruocco, L Criscuolo, A Villani… - World journal of …, 2023 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the most frequent liver neoplasm, and its incidence rates
are constantly increasing. Despite the availability of potentially curative treatments (liver …

Liver cancer cell of origin, molecular class, and effects on patient prognosis

D Sia, A Villanueva, SL Friedman, JM Llovet - Gastroenterology, 2017 - Elsevier
Primary liver cancer is the second leading cause of cancer-related death worldwide and
therefore a major public health challenge. We review hypotheses of the cell of origin of liver …

Update in global trends and aetiology of hepatocellular carcinoma

P Rawla, T Sunkara, P Muralidharan… - Contemporary Oncology …, 2018 - termedia.pl
Hepatocellular carcinoma (HCC) is the most common primary cancer of the liver responsible
for an increasing number of cancer-related deaths, especially in develo** economies of …

Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents

F Kanwal, J Kramer, SM Asch, M Chayanupatkul… - Gastroenterology, 2017 - Elsevier
Background and Aims The risk of hepatocellular cancer (HCC) after sustained virological
response (SVR) with direct-acting antivirals (DAA) is unclear. Our aim was to examine the …